ArticleThoracic cancer2024

First-line chemoimmunotherapy for patients with small-cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis.

Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.